Rationale The rapid membrane actions of neuroactive steroids, particularly via an enhancement of γ-aminobutyric acid A receptors (GABA A Rs), participate in the regulation of central nervous system excitability. Prior evidence suggests an inverse relationship between endogenous GABAergic neuroactive steroid levels and behavioral changes in excitability during ethanol withdrawal. Objectives Previously, we found that ethanol withdrawal significantly decreased plasma allopregnanolone (ALLO) levels, a potent GABAergic neuroactive steroid, and decreased GABA A R sensitivity to ALLO in Withdrawal Seizure-Prone (WSP) but not in Withdrawal Seizure-Resistant (WSR) mice. However, the effect of ethanol withdrawal on levels of other endogenous GABA A R-active steroids is not known. Methods After validation of a gas chromatography-mass spectrometry method for the simultaneous quantification of ten neuroactive steroids, we analyzed plasma from control male WSP-1 and WSR-1 mice and during ethanol withdrawal.
Introduction
Neuroactive steroids are synthesized in the brain and periphery and have rapid and potent effects on γ-aminobutyric acid A receptors (GABA A Rs) and other ligand-gated ion channels to alter neuronal activity (Belelli and Lambert 2005; Finn and Purdy 2007; Paul and Purdy 1992; Reddy 2010) . Because the enzymes identified in classic steroidogenic tissues are found in the nervous system (Mellon and Vaudry 2001) , the endogenous concentration of neuroactive steroids in the brain likely reflects a combination of neuroactive compounds produced there de novo as well as steroids derived from circulating precursors but metabolized to neuroactive compounds in the brain. The GABA A R-active neuroactive steroids allopregnanolone (ALLO; 3α,5α-THP), pregnanolone (3α,5β-THP), tetrahydrodeoxycorticosterone (3α,5α-THDOC), and 3α,5α-androstanediol are formed from the 2-step reduction of the parent steroid progesterone (in the case of both THPs), deoxycorticosterone, and testosterone, respectively (Fig. 1) . The three most potent pregnane neuroactive steroids characterized to date (ALLO, 3α,5α-THDOC, and pregnanolone) have nanomolar (nM) potencies at GABA A Rs (e.g., Belelli et al. 1990; Purdy et al. 1990; Ruppercht and Holsboer 1999; Veleiro and Burton 2009) . Because endogenous concentrations fluctuate in the 10-100-nM range (Barbaccia et al. 2001; Belelli and Lambert 2005; Finn et al. 2004; Paul and Purdy 1992) , these GABA A R-mediated actions undoubtedly participate in the regulation of central nervous system (CNS) excitability and have significance in response to physiological conditions such as stress, trauma, and hormonal changes (i.e., pregnancy, puberty, aging, menstrual, or estrous cycle changes). Thus, rapid membrane effects of certain specific metabolites of steroid hormones at GABA A Rs provide a mechanism by which these metabolites can influence brain function and behavior, in addition to the classical genomic actions of the parent steroid hormones.
The interaction of alcohol (ethanol) at GABA A Rs is integral for the development of tolerance and withdrawal-related convulsive activity, both of which contribute to the behavioral transition from recreational ethanol use to dependence and addiction (e.g., Devaud et al. 2006; Finn et al. 2010; Folessa et al. 2006; Grobin et al. 1998; Kumar et al. 2009; Liang et al. 2004 Liang et al. , 2006 Liang et al. , 2009 McKeon et al. 2008) . Numerous lines of evidence indicate that the transition from acute ethanol intoxication to dependence and the expression of withdrawal involves plasticity of GABA A R properties with regard to direct and indirect effects of ethanol on GABA A R function, including the synthesis of endogenous GABA A R-active neuroactive steroids (see Kumar et al. 2009 ). In particular, chronic ethanol consumption and the induction of physical dependence reduce ethanol's steroidogenic effect (Boyd et al. 2010) , and withdrawal from chronic ethanol exposure decreased ALLO levels in rodents and humans Finn et al. 2004; Hill et al. 2005; Romeo et al. 1996; Tanchuck et al. 2009 ) and reduced sensitivity of the GABA A R system to ALLO in rodents with severe ethanol withdrawal (e.g., Finn et al. 2000 Finn et al. , 2006 . And, the decrease in GABA A R-active neuroactive steroid levels corresponded to an increase in the subjective ratings of anxiety and depression during days 4 and 5 of withdrawal, when compared with control human subjects (Hill et al. 2005; Romeo et al. 1996 Romeo et al. , 2000 . Collectively, the data suggest that the withdrawal-induced reduction in endogenous ALLO levels and reduced sensitivity of GABA A Rs to ALLO contributes to increased cellular excitability and associated aversive behavioral effects of ethanol withdrawal.
Two independent genetic replicate lines of Withdrawal Seizure-Prone (WSP) and -Resistant (WSR) mice were selectively bred to have severe (WSP) or mild (WSR) chronic ethanol withdrawal severity after exposure to 72 h ethanol vapor to induce physical dependence (Crabbe et al. 1985) . Studies in our laboratory have used these selected lines to test the hypothesis that genetic differences in ethanol withdrawal severity were due in part to alterations in the GABA A R modulatory effects of neuroactive steroids such as ALLO. When we measured ALLO levels with radioimmunoassay (RIA), we found that plasma ALLO levels were significantly decreased in both replicate lines of WSP (but not in WSR) mice that were dependent or undergoing withdrawal, and this corresponded to a decrease in adrenal expression of 5α-reductase (Tanchuck et al. 2009 ), one rate-limiting enzyme in ALLO biosynthesis (Fig. 1) . Although cortical ALLO and 5α-reductase activity was decreased to a similar degree in the WSP and WSR lines during withdrawal, hippocampal 5α-reductase activity and expression were decreased only in dependent WSP mice. Unfortunately, because of the small size of the mouse hippocampus, we were unable to measure hippocampal ALLO levels with RIA. However, previous work in rats showed that withdrawal-induced decreases in expressions of 5α-reductase and 3α-hydroxysteroid dehydrogenase corresponded to a decrease in hippocampal ALLO levels in rats , suggesting that the chronic ethanol-induced decrease in hippocampal 5α-reductase activity in WSP mice might produce a corresponding decrease in hippocampal ALLO levels. Collectively, the evidence suggests that during ethanol withdrawal in WSP and WSR mice, there are line-specific changes in ALLO levels in plasma and some brain regions, but the effect of ethanol withdrawal on levels of other endogenous GABA A R-active neuroactive steroids is not known. Considering that steroid synthesis is a dynamic process and that disruptions in one or more steps could impact levels of multiple steroids with positive or negative modulatory effects at GABA A Rs, it is likely that levels of several neuroactive steroids work in concert to coordinate the physiological regulation of CNS excitability.
Recent elegant work ) utilized gas chromatography-mass spectrometry (GC-MS) to simultaneously quantify levels of eight neuroactive steroids and the precursor pregnenolone. Here, we have validated the method utilized by Porcu et al. (2009) in our laboratory and achieved good resolution with the simultaneous identification of a panel of ten neuroactive steroids, which included pregnenolone, dehydroepiandrosterone (DHEA), and the 3α,5α-and 3α,5β-GABA A R-active metabolites of DHEA, deoxycorticosterone, progesterone, and testosterone. Next, we quantified levels of these ten neuroactive steroids in plasma from WSP and WSR mice from the first genetic replicate (i.e., WSP-1 and WSR-1; control and ethanol withdrawal). We predicted that a larger imbalance in ALLO and other GABA A R-active neuroactive steroids would be evident in WSP-1 versus WSR-1 mice during ethanol withdrawal, which would contribute to a decrease in GABA A R inhibition and the severe withdrawal phenotype in WSP-1 mice.
Materials and methods
Animals Drug-naïve male WSP and WSR mice from the first pair of replicate lines (WSP-1, WSR-1) were kindly provided by Dr. John C. Crabbe. The animals were bred in the Veterinary Medical Unit at the Veterans Affairs Medical Center (Portland, OR), were housed four per cage with ad libitum access to food and water upon weaning, and were acclimated to a 12:12 h light/dark cycle (lights on at 0600). At the time of testing, mice were from selected generation 26 (filial generation 130) and were 73-104 (WSP-1) or 77-94 (WSR-1) days old. All procedures complied with the United States Public Health Service Institutes of Health guidelines in accordance with the "Guidelines for the Care and Use of Mammals in Neuroscience and Behavioral Research" and were approved by the local Institutional Animal Care and Use Committee.
Chronic ethanol exposure Separate groups of animals were exposed to ethanol vapor or air for 72 h by the Portland Alcohol Research Center, using a standardized method for inducing ethanol dependence (Finn and Crabbe 1999; Tanchuck et al. 2009; Terdal and Crabbe 1994) . Blood ethanol concentration (BEC) was analyzed by headspace gas chromatography, as previously described ). Animals were euthanized at a time corresponding to peak withdrawal (6-9 h) after removal from the inhalation chambers. Trunk blood was collected for plasma neuroactive steroid analysis by GC-MS in 100 μl samples. Plasma corticosterone (CORT) 5α-Reductase 5β-Reductase Fig. 1 Biosynthesis of selected neuroactive steroids. Steroids that were simultaneously quantified in the GC-MS assay are indicated with a Bold asterisk. Note that the potent positive modulators of GABA A receptors (THP, THDOC, androstanediol) are formed by the two-step reduction of the parent steroids, progesterone, deoxycorticosterone, and testosterone, respectively. Also depicted are the sulfated derivatives of pregnenolone and DHEA (dehydroepiandrosterone), which are negative modulators of GABA A receptors. DHDOC dihydrodeoxycorticosterone, THDOC tetrahydrodeoxycorticosterone, DHP dihydroprogesterone, THP tetrahydroprogesterone, DHT dihydrotestosterone, HSD hydroxysteroid dehydrogenase levels were measured with a commercially available double antibody RIA kit (MP Biomedicals, Solon, OH) in 5 μl samples, as described recently (Ford et al. 2013) .
Chemicals All extraction and derivatization solvents were chromatography grade from EMD Chemicals (Billerica, MA). Monodeuterated ethanol was obtained from Acros Organics (New Jersey), and heptafluorobutyric acid anhydride was obtained from Fluka (Sigma-Aldrich, St. Louis, MO). Pregnenolone, pregnanolone, 3α,5β-THDOC, and 3α,5β-androstanediol were procured from Steraloids (Newport, RI), and all other native steroid standards were synthesized by Dr. Robert Purdy (Scripps Research Institute, La Jolla, CA). The internal standard (ISTD) that was used in all assays was 17β-estradiol-2,4,16,16,17-d5 (CDN Isotopes, Pointe-Claire, Quebec, Canada). Stripped human serum (SHS) was purchased from Gemini Bioproducts (West Sacramento, CA).
Extraction Steroids were extracted from plasma using solid phase extraction (SPE) techniques. Plasma (100 μl) was spiked with 1,000 pg of estradiol-d5 (ISTD), which was selected for its robust ionizability in the derivative form and its elution midfield to the analytes of interest. The extracted sample was then loaded on a Strata-X 33u Polymeric Reversed Phase SPE column (8B-S100-UBJ, 60 mg/3 ml, Phenomenex, Torrance, CA), pre-conditioned with 4 ml of dichloromethane, conditioned with 4 ml of acetonitrile, and then equilibrated with 4 ml of deionized water. After loading, the samples were washed with 1 ml of deionized water, and then, the SPE columns were dried on a Waters vacuum manifold (WAT200608, Waters, Milford, MA) for 30 min at 12 inHg (inches of mercury, a unit of pressure equal to 0.49 psi) of vacuum. The steroids were then eluted from the SPE columns with 1.5 ml of acetonitrile, and the resulting eluate was dried on an Eppendorf Vacufuge for 90 min (ambient temperature, program 1). The samples were then derivatized or stored in a vacuum desiccator for up to 24 h.
Derivatization Extracted samples were solvated in acetonitrile (450 μl), and heptafluorobutyric acid anhydride (HFAA, 50 μl) was added. The reagent mixture was capped and left at ambient temperature for 120 min to allow esterification of 3, 17, and 21 hydroxyl active groups and the resultant formation of perfluoroacyl steroid species. The mixture was then dried for 90 min using an Eppendorf Vacufuge (ambient temperature, program 1), leaving only dried derivatized extractant. The samples were then resolvated in acetonitrile (10 μl) and transferred to a deactivated vial insert for immediate analysis.
Gas chromatography-mass spectrometry Analysis of samples and calibration curves was performed on an Agilent 7890A gas chromatograph coupled to an Agilent 5975C mass spectrometer detector (Agilent Technologies, Santa Clara, CA). Aliquots of 2 μl of the samples and calibration curve standards were injected into a 275°C inlet at 12.696 psi. Chromatographic separation was carried out on an HP-5 ms capillary column (30 m×0.250 mm, 0.25-mm film, Agilent Technologies) at an isobaric flow rate of 0.944 ml/min of helium carrier gas (UHP 5.0 grade, Matheson, Tualatin, OR) with a total run time of 31.41 min. A temperature gradient was employed with an initial oven temperature of 75°C for 0.86 min, leading to the first ramp to 210°C (35°C/min) with a hold for 3 min, then a ramp to 235°C (3.25°C/min) with a hold for 11 min, and a final ramp to 310°C (25°C/min) and a hold for 2 min. The transfer line was isothermic at 280°C. Eluates were then analyzed by the mass spectrometer in negative chemical ionization (NCI) using methane (research grade 99.999 %, Matheson Tri-gas, La Porte, TX) as the reagent gas at a flow rate of 40 %. Both mass spectrometer chemical ionization source and quadrupole mass filter temperatures were set at 150°C. A solvent delay of 14.00 min was established. Selected ion monitoring (SIM) was used, and data were collected for a minimum of two ions per analyte over five retention period groups (Table 1) .
Calibration curves Calibration curves were formed by spiking 300 μl of deionized water with 0, 10, 50, 100, 500, 1,000, and 3,000 pg of all ten analytes of interest. The spiked reference standards were then extracted and derivatized in the identical manner as described above and analyzed via GC-MS. Curves were formed by plotting the ratio of the responses of the analyte divided by the response of the ISTD versus the concentration of the analyte. The response constituted an integration of the abundance counts collected by the MS detector horn for the target ion from baseline to baseline for each peak representing an analyte of interest. No analytes coeluted with other analytes or with the ISTD. The calibration curves were then analyzed with linear regression, and unknown plasma samples were interpolated against these regression parameters using their individual response ratios.
Data analysis Target ion peaks were integrated in ChemStation and interpolated using Prism5 (GraphPad Software Inc., San Diego, CA). Mean picograms per milliliter of neuroactive steroid per extracted sample was calculated from the interpolated values and statistically analyzed with analysis of variance (ANOVA). Two-way ANOVA assessed line and treatment effects. A similar strategy was used for the analysis of CORT levels. Significant interactions were followed up with one-way ANOVA. Because we predicted line differences in basal neuroactive steroids, significant line effects were examined in the air controls, even in the absence of a significant interaction. Significance was set at a p value of ≤0.05.
Results
Gas chromatography-mass spectrometry We were able to simultaneously quantify ten different neuroactive steroids (see Fig. 1 ; steroids with an asterisk). We employed SIM during GC-MS analysis to quantify abundances of selected ions per time point. This allowed for both identification of each analyte based on its target ion, qualifier ion(s), and retention times (Table 1) as well as quantification of each analyte by integration of abundances for the target ion at the appropriate retention time. The SIM programming was divided into five SIM groups to limit the maximum of ions tracked per period to six, to ensure ample dwell time per ion and adequate scan rate to obtain approximately 10-14 scans per peak. As shown in Fig. 2 , all analytes were resolved chromatographically with no coelution of analytes or ISTD.
Detection limits of the analytes Several factors contributed to sensitivity in the assay, such as ionizability of the derivatized analyte, ion mass selectivity within the quadrupole based on tune parameters, or biased acylation during derivatization due to steric hindrance variability between epimers. However, detection limits were very good for the analytes of interest. The lowest amount in the calibration standard curves that was reliably detected for 3α,5α-and 3α,5β-androstanediol as well as for 3α,5α-and 3α,5β-androsterone was 2 pg per 2-μl aliquot. DHEA, ALLO, pregnanolone, pregnenolone, and 3α,5β-THDOC were detectable at ≥10 pg per 2-μl aliquot, whereas 3α,5α-THDOC was detectable at 20 pg per 2-μl aliquot. These limits of detection are similar to those previously reported in Porcu et al. (2009) . The minimum allowable signal to noise ratio for the GC-MS peaks was three to one, which was the case on occasion for pregnenolone and the THDOCs. However, for all other steroids (even for pregnenolone and the THDOCs under most circumstances), the signal to noise ratio was equal to or greater than 5 to 1. There was high response and good resolution for all analytes of interest;
x-axis depicts range of retention times (min) for elution of the steroids (also see Table 1 ); y-axis depicts abundance. Testosterone derivatives= 3 α , 5 α -A -D i o l a n d 3 α , 5 β -A -D i o l ( a n d r o s t a n e d i o l s ) ; androstenedionederivatives=3α,5α-A and 3α,5β-A (hydroxyandrostan-17-ones); progesterone derivatives=3α,5α-THP (allopregnanolone) and 3α,5β-THP (pregnanolone); deoxycorticosterone derivatives=3α,5α-THDOC and 3α,5β-THDOC (tetrahydrodeoxycorticosterones). See Fig. 1 for parent steroids Calibration curves Analytes in extracted samples were quantified by interpolating integrated abundances against calibration curves formed by reference standards (0, 10, 50, 100, 500, 1,000, and 3,000 pg), which were run in the concurrent sequence. Each neuroactive steroid had its own calibration curve (Fig. 3) that was formed by plotting the ratio of the response of the analyte divided by the response of the ISTD versus the concentration of the analyte. The r 2 values from linear regression analysis of each calibration curve for the ten neuroactive steroids ranged from 0.9934 to 0.9999, confirming an excellent linear response for all analytes. A solvent wash of acetonitrile (5 μl) was conducted every third run during the sequences to limit carryover from previous runs.
Method validation Because we modified the GC-MS assay that was utilized by Porcu et al. (2009) , we conducted four experiments to verify the accuracy and reproducibility of the current GC-MS procedure. SHS (200 μl) was spiked with either 30, 300, or 700 pg of the panel of ten neuroactive steroids, and then extracted, derivatized, and analyzed with GC-MS as if they were plasma samples. The concentrations chosen represented a fairly wide range of the calibration curve and covered quantities typically found in biological samples. The subsequent abundances were integrated and interpolated against the concurrently run calibration curves, and the resulting interpolated values were plotted against the spiked amount (Fig. 4) . Linear regression analysis on the obtained amounts also confirmed the excellent linear response for all neuroactive steroids. The r 2 values ranged from 0.9915 to 0.9996, with the exception of pregnenolone, where r 2 was 0.9832. Notably, the interpolated values of the analytes were statistically similar or identical to the spiked amount, indicating a high level of accuracy in the assay. A nonspiked SHS blank also was analyzed in each experiment, and low levels of 3α,5β-androsterone were detected, leading to a skewing in the obtained amount of that steroid (particularly in the 700-pg spiked sample). The higher obtained levels of 3α,5β-androsterone in the analytical validation is similar to that reported by Porcu et al. (2009) .
Intra-assay and inter-assay variability Inter-assay variability was conducted on the validation points from four assays, similar to Porcu et al. (2009) . Values ranged from 4.3 to 15.3 % for six of the steroids, with slightly higher values for 3α,5β-androstanediol (19.4 %), pregnenolone (21.0 %), 3α,5α-THDOC (23.3 %), and 3α,5β-THDOC (21.9 %). Intra-assay variability was calculated on the data from the calibration curves depicted in Fig. 3 . Briefly, the standards were used as unknowns, and interpolated values were calculated for each standard. The coefficients of variation were calculated as described by Porcu et al. (2009) , and intra-assay variability ranged from 8.5 to 16.5 %.
Effect of chronic ethanol withdrawal on plasma neuroactive steroid levels We were able to quantify levels of nine neuroactive steroids in the plasma of WSP-1 and WSR-1 mice following exposure to 72 h ethanol vapor or air (Fig. 5) . Pregnanolone (3α,5β-THP) was not detected, presumably because endogenous levels were below our detection threshold. For the ethanol-exposed mice, BEC upon removal from the vapor chambers at 72 h was 1.598±0.098 mg/ml for WSP-1 mice and 1.591±0.161 mg/ml for WSR-1 mice. Values from the two-way ANOVAs are provided in Table 2 .
There was a main effect of selected line for all steroids examined except pregnenolone and 3α,5α-THDOC, with higher levels of neuroactive steroids in WSR-1 versus WSP-1 mice. Post hoc analysis of the air controls confirmed that basal plasma levels of DHEA (↑414 %, p<0.001; Fig. 5b ), 3α,5α-androstanediol (↑244 %, p<0.001; Fig. 5d ), 3α,5β-androstanediol (↑403 %, p<0.001; Fig. 5e ), 3α,5α-androsterone (↑319 %, p<0.001; Fig. 5f ), and 3α,5β-androsterone (↑765 %, p=0.01; Fig. 5g ) were significantly higher in WSR-1 versus WSP-1 mice. A trend for higher basal ALLO (↑54 %, p=0.06; Fig. 5c ) and 3α,5β-THDOC (↑253 %, p= 0.06; Fig. 5i ) in WSR-1 mice also was observed. In contrast, pregnenolone levels (Fig. 5a ) were 45 % higher in air-exposed WSP-1 versus WSR-1 mice, but this difference was not statistically significant.
Ethanol withdrawal produced a significant suppression in the levels of five neuroactive steroids in WSP-1 and WSR-1 mice, respectively (main effect of treatment, see Table 2 ): DHEA (↓47 %, ↓61 %), ALLO (↓39 % in both lines), 3α,5α-androstanediol (↓32 %, ↓39 %), 3α,5β-androstanediol (↓78 %, ↓70 %), and 3α,5α-androsterone (↓56 % in both lines) (Fig. 5 ). There was a trend (p<0.07) for a decrease in 3α,5β-THDOC levels during withdrawal. The interaction between main effects for DHEA (Fig. 5b) , 3α,5β-androstanediol (Fig. 5e) , and 3α,5α-androsterone (Fig. 5f ) appears to be due to the higher basal neuroactive steroid levels in WSR-1 versus WSP-1 mice (mentioned above) as additional post hoc tests revealed similar decreases in neuroactive steroid levels during ethanol withdrawal for DHEA, 3α,5β-androstanediol, and 3α,5α-androsterone (also see above). For 3α,5β-androsterone (Fig. 5g) , post hoc tests indicated that levels were significantly increased (by 96 %) during withdrawal in WSP-1 mice and nonsignificantly decreased (by 53 %) during withdrawal in WSR-1 mice. In contrast, pregnenolone (Fig. 5a ) was significantly decreased (by 63 %) during withdrawal in WSP-1 mice and nonsignificantly increased (by 72 %) during withdrawal in WSR-1 mice. Thus, for both of these neuroactive steroids, pregnenolone, and 3α,5β-androsterone, ethanol withdrawal produced divergent changes in WSP-1 and WSR-1 mice.
Because we were concerned that small sample sizes may have led us to fail to detect some meaningful differences, we computed effect sizes, and they were consistent with moderate (0.50) to large (0.80) effects (Cohen 1988) . For most of the significant differences observed, the effect size was >0.80, and two significant differences had effect sizes of 0.57 and 0.59. The three nonsignificant trends had effect sizes of 0.56 (ALLO, basal difference), 0.52 (3α,5β-THDOC, basal difference), and 0.31 (3α,5β-THDOC, treatment). The effect sizes for the nonsignificant results for 3α,5α-THDOC were 0.18 and 0.30. Thus, despite a low group size, the large effect size implies that the power was sufficient to support the significant differences that were observed.
Effect of chronic ethanol withdrawal on plasma CORT levels Mean ± SEM basal plasma CORT levels were 26.14± 2.62 μg/dl for WSP-1 mice (n=7) Reference standards (0, 10, 50, 100, 500, 1,000, and 3,000 pg) were plotted against the ratio of the responses of the analyte over the response of the internal standard per sample (2 μl). Data are the mean ± SEM of three experiments for each neuroactive steroid, which are depicted in two separate panels. The top panel contains the 3α,5α-and 3α,5β-androstanediols and the 3α,5α-and 3α,5β-androsterones; the bottom panel contains DHEA, the 3α,5α-and 3α,5β-THPs, pregnenolone, and the 3α,5α-and 3α,5β-THDOCs WSR-1 mice (n=5). Ethanol withdrawal produced a similar (~100 %) increase in plasma CORT concentrations in WSP-1 (52.50±4.46 μg/dl, n=7) and WSR-1 (51.51±9.48 μg/dl, n= 5) mice, a finding that is supported by the significant main effect of treatment [F(1,20) 
Discussion
The present results indicate that we were able to achieve good resolution with the simultaneous identification of ten neuroactive steroids, with a slight variation in the GC-MS assay recently published by Porcu et al. (2009) . The main differences involved the use of a single ISTD, deuterium-labeled 17β-estradiol, in the present study versus separate deuteriumlabeled ISTDs for each neuroactive steroid group ) as well as a novel extraction methodology incorporating a single SPE procedure. The retention time for 17β-estradiol was in the midrange of retention times for all the neuroactive steroid analytes (Table 1) , and the peak was easily resolved and separable from the neuroactive steroids with the closest retention times (DHEA and 3α,5β-androsterone). Importantly, the high resolution and distinct retention times ensured that interference did not produce false estimates of neuroactive steroid levels. The validation of the GC-MS assay in spiked SHS confirmed the high level of accuracy in the current GC-MS assay. Thus, the present findings confirm that we are able to simultaneously identify and quantify ten neuroactive steroids: the GABA A R-active reduced metabolites (i.e., 3α,5α-and 3α,5β-) of progesterone, testosterone, deoxycorticosterone, and DHEA as well as the precursor steroid pregnenolone and DHEA. We recognize that it is not optimal to utilize a single ISTD, based on recommendations that an ideal ISTD should have the same physical and chemical properties as the analyte of interest but also have the ability to be separated by mass, as is found with the use of a deuterated analog of the analyte of interest that differs by 3-5 atomic mass units (e.g., Alomary et al. 2001) . Initially, we used 5α-pregnane-3α, 21-diol-20-one-17,21,21-d 3 , 5-androsten-3β-ol-17-one-16,16-d 2 , 5-pregnen-3β-ol-20-one-17,21,21,21-d 4 , and 5α-adrostan-3α-ol-17-one-16,16-d 2 as ISTDs in an attempt to be as analogous as possible to the analytes in each of our SIM groupings, as was done by Porcu et al. (2009) . Unfortunately, the capabilities of our mass spectrometer, which utilizes a single quadrupole mass filter, did not allow for mass resolution between the native species and the deuterated species, even with the m+4 deuterated analog. Upon consultation and recommendations by several experts in the GC-MS analysis of steroids, we chose 17β-estradiol-2,4,16,16,17-d 5 as the ISTD for several reasons. First, estradiol has similar structure, derivatization characteristics, and chromatographic tendencies as the analytes of interest. It is a prime candidate for reference to our analytes of interest, as it has similar polarity and heteroatomic substitutions, leading to extraction response consistent to our analytes of interest. It also has two hydroxyl substitutions, allowing for double acylation by the derivatizing agent as is the case with half of our analytes of interest, and it produces excellent ionization in the mass spectrometer source. Further, chromatographically, it has retention properties in our method so that it elutes in the middle of our analytes of interest. Most importantly, in using the ratio of response of the deuterated estradiol to each individual analyte of interest, correlation values of 0.99 or above were achieved for the calibration curves for each analyte. If the response was not analogous, then it is unlikely that we would achieve these correlations.
GC-MS analysis was conducted on plasma from WSP-1 and WSR-1 male mice exposed to air (controls) or 72 h ethanol vapor and euthanized at a time corresponding to peak withdrawal in WSP mice. The goal was to extend our previous analysis of selected line differences in ALLO levels during ethanol withdrawal, which relied on a RIA-based method. Our earlier study (Tanchuck et al. 2009) found that plasma ALLO levels were decreased by 34 % during withdrawal in WSP but not in WSR mice from both genetic replicates. This finding also corresponded to a downregulation of adrenal 5α-reductase during ethanol withdrawal in WSP mice. However, in the present study, we observed a 39 % decrease in plasma ALLO levels during withdrawal in both WSP-1 and WSR-1 mice. It is possible that the exclusive use of replicate-1 animals in the present study, or the different methods of analysis (i.e., GC-MS vs RIA), accounts for this discrepancy. Yet, we did not observe replicate-1 versus replicate-2 differences in the Tanchuck et al. (2009) study, making a replicate line explanation unlikely. Regardless, a withdrawal-induced suppression in ALLO levels during ethanol withdrawal is consistent with prior evidence in humans and rodents (e.g., Cagetti et al. 2004; Finn et al. 2004; Hill et al. 2005; Romeo et al. 1996 Romeo et al. , 2000 Tanchuck et al. 2009 ). Notably, studies in rodents Fig. 4 Validation of assay by determination of spiked serum samples.
Stripped human serum (SHS, 200 μl) was spiked with internal standard and three selected concentrations (30, 300, and 700 pg/sample) of each neuroactive steroid and extracted in the same manner as the reference standards. The resultant interpolated values (obtained amount solid triangle with dashed line, from a standard curve of each analyte) are plotted along with the value for the amount added to the sample (spiked amount white square with solid line). The r 2 values from the linear regression on the obtained amounts (solid triangle) ranged from 0.9915 to 0.9996 for all analytes except pregnenolone, where r 2 =0.9832. Data are the mean ± SEM of four experiments per analyte. Note the different range in y-axis for 3α,5β-androsterone also determined that ethanol withdrawal did not significantly alter levels of the precursor progesterone Finn et al. 2004) , while expression of 5α-reductase and 3α-hydrosteroid dehydrogenase (3α-HSD) was suppressed (e.g.,
b.
c.
d. e.
f. g.
h. i.
a. Cagetti et al. 2004) . Collectively, these results suggest that an ethanol withdrawal-induced decrease in ALLO levels is not due to a concomitant decrease in progesterone and that it likely involves an effect on 5α-reductase and 3α-HSD, the two biosynthetic enzymes downstream of progesterone that are important for ALLO synthesis (see Fig. 1 ).
When considering the pattern of the results across the GABA A R-active neuroactive steroids examined, there was a significant suppression in the levels of five neuroactive steroids (including ALLO) during ethanol withdrawal in WSP-1 and WSR-1 mice. The GABA A R-active testosterone metabolites, 3α,5α-and 3α,5β-androstanediol, were decreased by 32 or 39 % (3α,5α-) and by 78 or 70 % (3α,5β-) during ethanol withdrawal in WSP-1 and WSR-1 mice, respectively. Recent work indicated that serum testosterone was significantly decreased at the 8 h withdrawal time point in male WSP and WSR mice (Forquer et al. 2011) , suggesting that ethanol withdrawal produced a similar suppression in the biosynthesis of testosterone and its GABA A R-active metabolites in male WSP and WSR mice in the present study. This finding is consistent with the reported decrease in plasma testosterone levels in male alcoholics (e.g., Castilla-Garcia et al. 1987; Iturriaga et al. 1999; Krüger et al. 2006; Maneesh et al. 2006; Martínez-Riera et al. 1995; Ruusa et al. 1997; Sierksma et al. 2004; Ylikahri et al. 1980) . Ethanol withdrawal also produced a similar decrease (56 %) in levels of the GABAergic DHEA metabolite 3α,5α-androsterone in WSP-1 and WSR-1 mice, which corresponded to a withdrawalinduced suppression in levels of the parent steroid DHEA (↓ 47 % in WSP, ↓ 61 % in WSR). While we did not measure plasma levels of the sulfated form of DHEA (i.e., DHEAS), the present results with DHEA are consistent with a reported decrease in DHEAS in a small cohort of alcoholic patients during the early withdrawal phase (Ozsoy and Esel 2008) . Overall, findings to date suggest that a consistent suppression in the DHEA and testosterone steroid pathways occurs during ethanol withdrawal in male WSP-1 and WSR-1 mice.
It is interesting that plasma pregnenolone was suppressed by 63 % during ethanol withdrawal only in WSP-1 but not in WSR-1 mice. This finding would be consistent with an overall suppression of steroid synthesis during withdrawal in WSP-1 mice, given that pregnenolone is the precursor of all the steroids examined ( Fig. 1 ), but it also would suggest that ethanol withdrawal was altering steroid synthesis at a step downstream from pregnenolone in WSR-1 mice. However, we have found previously that ethanol withdrawal did not decrease plasma progesterone levels in WSP or WSR mice (Finn et al. 2004 ) and plasma CORT levels were significantly increased during withdrawal in both WSP and WSR mice in the present and prior work (Tanchuck et al. 2009 ). Taken in conjunction with nonsignificant changes in the GABA A Ractive deoxycorticosterone metabolites, 3α,5α-and 3α,5β-THDOC, it is likely that ethanol withdrawal is exerting independent effects at several steps in the steroidogenic pathway rather than an overall suppression in steroid synthesis.
While plasma ALLO and related GABA A R-active neuroactive steroids were significantly decreased during ethanol withdrawal in both WSP-1 and WSR-1 male mice, absolute values of the neuroactive steroids during ethanol withdrawal also should be considered, as a decrease below the physiologically relevant range would no longer potentiate GABA A R function. Since basal neuroactive steroid levels were lower in Fig. 5 Effect of chronic ethanol withdrawal on plasma neuroactive steroid levels in male WSP-1 and WSR-1 mice. Mice were exposed to 72 h ethanol vapor or air and euthanized at a time corresponding to peak withdrawal in WSP-1 mice (6-9 h after removal from the inhalation chambers). Basal neuroactive steroid levels (air controls) were significantly higher in WSR-1 versus WSP-1 mice for five of the nine steroids depicted, and ethanol withdrawal significantly decreased neuroactive steroid levels in five of the nine steroids examined. The mean ± SEM neuroactive steroid levels are shown in pg/ml; note the different ranges in the y-axes. Group size for WSP-1 mice was 5 (air) and 7 (ethanol), except for 3α,5α-androstanediol, where n=6 (ethanol). Groups size for WSR-1 mice was 5 (air) and 4 (ethanol). *p<0.05, **p<0.01, ***p≤0.001 versus respective air control (main effect of treatment for panels b-f; post hoc test for panels a, g);
•• p<0.01,
.001 versus respective WSP-1 (post hoc test) Results for the two-way ANOVAs are shown for the nine neuroactive steroids (and in the same order) that are depicted in Fig. 5 WSP-1 versus WSR-1 mice for five of the steroids examined, a withdrawal-induced decrease in WSP-1 mice may have a greater physiological consequence versus a similar decrease in WSR-1 mice (e.g., 3α,5α-and 3α,5β-androstanediols). Additionally, based on evidence that brain and peripheral neuroactive steroid synthesis can be regulated independently, it is possible that the withdrawal-induced changes in plasma neuroactive steroid levels in the present study do not reflect local changes in discrete brain regions. Consistent with this idea, hippocampal 5α-reductase enzyme activity and gene expression was decreased only in dependent WSP mice from both genetic replicates (Tanchuck et al. 2009 ), suggesting that there may be brain regional and selected line differences in the effect of ethanol withdrawal on neuroactive steroid levels. Another interesting finding was that basal levels of five neuroactive steroids were significantly higher in WSR-1 versus WSP-1. This finding is consistent with the recent report of higher serum neuroactive steroid levels in C57BL/6J versus DBA/2J male mice (Porcu et al. 2010) , another genetic animal model of chronic ethanol withdrawal severity (i.e., mild withdrawal in C57BL/6J mice, severe withdrawal in DBA/2J mice). Because brain neuroactive steroid concentrations reflect a combination of de novo synthesis as well as peripheral sources, it is possible that greater fluctuations in circulating neuroactive steroids in WSR-1 and C57BL/6J mice result in higher brain concentrations than in WSP-1 and DBA/2J mice. Taken in conjunction with evidence that GABAergic neuroactive steroids modify the function of GABA A receptors in vivo and participate in the physiological control of CNS excitability (e.g., Belelli and Lambert 2005) , the selected line and inbred strain differences in basal GABA A R-active neuroactive steroid levels may have a physiologically significant consequence on GABA A R inhibition.
We also noticed that the basal plasma neuroactive steroid levels in the present study were significantly higher overall than those in the study by Porcu et al. (2010) in C57BL/6J and DBA/2J mice. And, the plasma ALLO levels in the present study were significantly higher than those in our earlier study (Tanchuck et al. 2009 ; if we converted the pg/ml ALLO concentrations to ng/ml). We suspected that the air exposure in the present study produced a greater activation of the hypothalamic-pituitary-adrenal (HPA) axis than that in our prior work, which was confirmed by our analysis of plasma CORT concentrations. In the present study, basal CORT levels were~26 μg/dl; these values are over 5-fold higher than those in our prior work (<5 μg/dl for both WSP and WSR mice; Tanchuck et al. 2009 ) and are associated with a moderate degree of stress. Ethanol withdrawal did produce a further activation of the HPA axis in the present study, measured by the 100 % increase in plasma CORT concentrations, but this increase was much lower than what we observed in our prior work (~6-fold increase in both WSP and WSR mice; Tanchuck et al. 2009 ). We do not know why exposure to 72 h air in the present study produced a greater activation of the HPA axis than in prior work as the methods and procedures were very similar, but this difference could explain the higher basal neuroactive steroid levels that were detected in the present study.
In conclusion, use of GC-MS to quantify GABAergic neuroactive steroids in male WSP-1 and WSR-1 mice indicated that there was a similar pattern of changes in 5 GABA A R-active neuroactive steroids during peak withdrawal. However, basal levels of five neuroactive steroids were lower in WSP-1 versus WSR-1 mice; so, a withdrawalinduced decrease in WSP-1 mice may have a greater physiological consequence versus a similar decrease in WSR-1 mice (e.g., 3α,5α-and 3α,5β-androstanediols). Additionally, it should be considered that ethanol withdrawal renders WSP mice (but not WSR) from both genetic replicates tolerant to the anticonvulsant effects of exogenous ALLO administration (e.g., Finn et al. 2006; Gililland-Kaufman et al. 2008; Tanchuck et al. 2013 ). This behavioral tolerance corresponded to a rightward shift in the ability of ALLO to potentiate GABA-stimulated chloride flux in forebrain microsacs (Finn et al. 2006) , consistent with a reduction in GABA A R sensitivity to GABA A R-active neuroactive steroids during ethanol withdrawal in WSP mice. And, recent preliminary results confirm a reduced sensitivity of extrasynaptic GABA A Rs to the GABA A R agonist THIP (gaboxadol) during ethanol withdrawal in male WSP-1 mice, measured by voltage clamp recordings of tonic GABA A R current responses in hippocampal dentate gyrus granule cells (Rossi and Finn unpublished) . Collectively, a withdrawal-induced decrease in GABA A R sensitivity to GABAergic neurosteroids and a concomitant decrease in endogenous GABAergic neurosteroid levels may represent a neurochemical substrate for enhanced susceptibility to ethanol withdrawal severity.
